SCHOTT Pharma AG & Co. KGaA / DE000A3ENQ51
18.08.2025 - 09:30:03SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
| EQS Preliminary announcement financial reports: SCHOTT Pharma AG & Co. KGaA / Preliminary announcement on the disclosure of financial statements SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] 18.08.2025 / 09:30 CET/CEST Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this announcement. SCHOTT Pharma AG & Co. KGaA hereby announces that the following financial reports shall be disclosed: Report Type: Financial report of the group (half-year/Q2) Language: German Date of disclosure: May 13, 2026 Address: https://www.schott-pharma.com/investor-relations/de/news-und-veroeffentlichungen/berichte-und-praesentationen Language: English Date of disclosure: May 13, 2026 Address: https://www.schott-pharma.com/investor-relations/news-publications/reports-and-presentations 18.08.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com |
| Language: | English |
| Company: | SCHOTT Pharma AG & Co. KGaA |
| Hattenbergstraße 10 | |
| 55122 Mainz | |
| Germany |
| End of News | EQS News Service |
| |
